A T Cell‐Engaging Tumor Organoid Platform for Pancreatic Cancer Immunotherapy
Zhuolong Zhou(Indiana University School of Medicine), Xiongbin Lu(Indiana University Health)
Cited by 55
Related Papers
PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints
|Genes & Development|2005|383
ST2 as checkpoint target for colorectal cancer immunotherapy
|JCI Insight|2020|52